Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction
Göster/Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2012Yazar
Ergelen, MehmetUyarel, Hüseyin
Altay, Servet
Ayhan, Erkan
Işık, Turgay
Bacaksız, Ahmet
Kemaloğlu, Tuba
Gül, Mehmet
Çiçek, Gökhan
14 readers on Mendeley
Üst veri
Tüm öğe kaydını gösterÖzet
Objectives We aimed to examine in-hospital and long-term outcomes of red blood cell (RBC) transfusions in patients undergoing a primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
Methods Overall, 2537 consecutive STEMI patients (mean age 56.2 +/- 11.7 years, 2111 men, 426 women) undergoing primary angioplasty were enrolled retrospectively into the present study. Patients were categorized according to whether they received RBC transfusions during hospitalization. Clinical characteristics, and in-hospital and long-term outcomes of the primary PCI were analyzed.
Results Of the consecutive 2537 patients, 88 (3.4%) received RBC transfusions during the index hospitalization. The transfused patients were older than nontransfused patients (mean age 63.6+/-12.1 vs. 56.2+/-11.8, P<0.001). Compared with nontransfused patients, female sex and hypertension were more prevalent in transfused patients (45.4 vs. 15.8%, P<0.001; 52.3 vs. 40.7%, P=0.04, respectively). Baseline values of hematocrit and hemoglobin were lower in patients receiving transfusion (33+/-6.2 vs. 40.2+/-4.7%, P<0.001; 11.1+/-2.3 vs. 13.7+/-1.6 mg/dl, P<0.001, respectively). The transfused patients had significantly higher in-hospital and long-term mortality (for in-hospital mortality: 10.2 vs. 2.7%, P<0.001; for long-term mortality: 14.1 vs. 5.1%, P=0.001). By multivariate Cox regression analysis, in all 2537 patients, RBC transfusion was found to be a powerful independent predictor of in-hospital cardiovascular mortality (odds ratio 8.31, P<0.001).